<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31755041</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1878-7479</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics</Title><ISOAbbreviation>Neurotherapeutics</ISOAbbreviation></Journal><ArticleTitle>Gender-Specific Beneficial Effects of Docosahexaenoic Acid Dietary Supplementation in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice.</ArticleTitle><Pagination><StartPage>269</StartPage><EndPage>281</EndPage><MedlinePgn>269-281</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13311-019-00808-2</ELocationID><Abstract><AbstractText>Docosahexaenoic acid (DHA) is an essential fatty acid modulating key nervous system functions, including neuroinflammation, and regulation of pre- and postsynaptic membrane formation. DHA concentration decreases in the lumbar spinal cord (LSC) of amyotrophic lateral sclerosis (ALS) patients and murine preclinical models. Using a dietary supplementation, we increased DHA levels (2% mean increase, p&#x2009;&lt;&#x2009;0.01) in the LSC of the familial ALS murine model B6SJL-Tg(SOD1*G93A)1Gur/J. This DHA-enriched diet significantly increases male mouse survival by 7% (average 10&#xa0;days over 130&#xa0;days of life expectancy), and delays motor dysfunction (based on stride length) and transgene-associated weight loss (p&#x2009;&lt;&#x2009;0.01). DHA supplementation led to an increased anti-inflammatory fatty acid profile (ca 30%, p&#x2009;&lt;&#x2009;0.01) and a lower concentration of circulating proinflammatory cytokine TNF-&#x3b1; (p&#x2009;&lt;&#x2009;0.001 in males). Furthermore, although DHA-treated mice did not exhibit generally decreased protein oxidative markers (glutamic and aminoadipic semialdehydes, carboxyethyllysine, carboxymethyllysine, and malondialdehydelysine), dietary intake of DHA reduced immunoreactivity towards DNA oxidative damage markers (8-oxo-dG) in the LSC. In vitro we demonstrate that DHA and &#x3b1;-tocopherol addition to a model of motor neuron demise (neonatal rat organotypic spinal cord model under chronic excitotoxicity) also preserves motor neuron number, in comparison with untreated spinal cords. Also, beneficial effects on cell viability were evidenced for the motor neuron cell line NSC-34 in front of H<sub>2</sub>O<sub>2</sub> insult (p&#x2009;&lt;&#x2009;0.001). Globally we show a sex-specific benefit of dietary DHA supplementation in the G93A ALS mouse model, compared with mice fed an isocaloric control or a n-3-depleted diet. These changes were associated with an increased DHA concentration in the LSC and were compatible with in vitro results showing DHA neuroprotective properties. These results suggest the need for further study on the interaction of gender-influenced biological parameters and DHA in ALS pathogenesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Torres</LastName><ForeName>Pascual</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Departament de Medicina Experimental, Institut de Recerca Biom&#xe8;dica de Lleida-Universitat de Lleida, Av. Rovira Roure 80, 25198, Lleida, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cacabelos</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Departament de Medicina Experimental, Institut de Recerca Biom&#xe8;dica de Lleida-Universitat de Lleida, Av. Rovira Roure 80, 25198, Lleida, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pairada</LastName><ForeName>J&#xe8;ssica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Departament de Medicina Experimental, Institut de Recerca Biom&#xe8;dica de Lleida-Universitat de Lleida, Av. Rovira Roure 80, 25198, Lleida, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bauer</LastName><ForeName>Kylynda C</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boada</LastName><ForeName>Jordi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Departament de Medicina Experimental, Institut de Recerca Biom&#xe8;dica de Lleida-Universitat de Lleida, Av. Rovira Roure 80, 25198, Lleida, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fontdevila</LastName><ForeName>Laia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Departament de Medicina Experimental, Institut de Recerca Biom&#xe8;dica de Lleida-Universitat de Lleida, Av. Rovira Roure 80, 25198, Lleida, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossi</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Departament de Medicina Experimental, Institut de Recerca Biom&#xe8;dica de Lleida-Universitat de Lleida, Av. Rovira Roure 80, 25198, Lleida, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Povedano</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Functional Unit of Amyotrophic Lateral Sclerosis (UFELA), Service of Neurology, Bellvitge University Hospital, Hospitalet de Llobregat, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrer</LastName><ForeName>Isidre</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Pathology and Experimental Therapeutics, University of Barcelona, Hospitalet de Llobregat, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Network Research Center on Neurodegenerative Diseases (CIBERNED), Institute Carlos III, Hospitalet de Llobregat, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pamplona</LastName><ForeName>Reinald</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Departament de Medicina Experimental, Institut de Recerca Biom&#xe8;dica de Lleida-Universitat de Lleida, Av. Rovira Roure 80, 25198, Lleida, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finlay</LastName><ForeName>B Brett</ForeName><Initials>BB</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Portero-Ot&#xed;n</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1823-0299</Identifier><AffiliationInfo><Affiliation>Departament de Medicina Experimental, Institut de Recerca Biom&#xe8;dica de Lleida-Universitat de Lleida, Av. Rovira Roure 80, 25198, Lleida, Spain. manuel.portero@mex.udl.cat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayala</LastName><ForeName>Vict&#xf2;ria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Departament de Medicina Experimental, Institut de Recerca Biom&#xe8;dica de Lleida-Universitat de Lleida, Av. Rovira Roure 80, 25198, Lleida, Spain. Victoria.Ayala@mex.udl.cat.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurotherapeutics</MedlineTA><NlmUniqueID>101290381</NlmUniqueID><ISSNLinking>1878-7479</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>25167-62-8</RegistryNumber><NameOfSubstance UI="D004281">Docosahexaenoic Acids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019587" MajorTopicYN="N">Dietary Supplements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004281" MajorTopicYN="N">Docosahexaenoic Acids</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012727" MajorTopicYN="N">Sex Characteristics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Polyunsaturated fatty acids</Keyword><Keyword MajorTopicYN="N">estrogens</Keyword><Keyword MajorTopicYN="N">n-3 fatty acids</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword><Keyword MajorTopicYN="N">protein oxidative modification</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31755041</ArticleId><ArticleId IdType="pmc">PMC7007454</ArticleId><ArticleId IdType="doi">10.1007/s13311-019-00808-2</ArticleId><ArticleId IdType="pii">10.1007/s13311-019-00808-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bruijn LI, Miller TM, Cleveland DW. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 2004;27:723&#x2013;749. doi: 10.1146/annurev.neuro.27.070203.144244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.neuro.27.070203.144244</ArticleId><ArticleId IdType="pubmed">15217349</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H, Guennoc AM, Veyrat-Durebex C. Amyotrophic lateral sclerosis: a hormonal condition? Amyotrophic Lateral Sclerosis. 2012;13:585&#x2013;588. doi: 10.3109/17482968.2012.706303.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.706303</ArticleId><ArticleId IdType="pubmed">22873563</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajroud-Driss S, Siddique T. Sporadic and hereditary amyotrophic lateral sclerosis (ALS) Biochim. Biophys. Acta. 1852;2015:679&#x2013;684.</Citation><ArticleIdList><ArticleId IdType="pubmed">25193032</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh M. Essential fatty acids, DHA and human brain. Indian J Pediatr. 2005;72:239&#x2013;242. doi: 10.1007/BF02859265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02859265</ArticleId><ArticleId IdType="pubmed">15812120</ArticleId></ArticleIdList></Reference><Reference><Citation>Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 2008;8:349&#x2013;361. doi: 10.1038/nri2294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2294</ArticleId><ArticleId IdType="pmc">PMC2744593</ArticleId><ArticleId IdType="pubmed">18437155</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson PA, Reay JL, Scholey AB, Kennedy DO. DHA-rich oil modulates the cerebral haemodynamic response to cognitive tasks in healthy young adults: a near IR spectroscopy pilot study. Br. J. Nutr. 2012;107:1093&#x2013;1098. doi: 10.1017/S0007114511004041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0007114511004041</ArticleId><ArticleId IdType="pubmed">22018509</ArticleId></ArticleIdList></Reference><Reference><Citation>Chytrova G, Ying Z, Gomez-Pinilla F. Exercise contributes to the effects of DHA dietary supplementation by acting on membrane-related synaptic systems. Brain Res. 2010;1341:32&#x2013;40. doi: 10.1016/j.brainres.2009.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2009.05.018</ArticleId><ArticleId IdType="pmc">PMC2884051</ArticleId><ArticleId IdType="pubmed">19446534</ArticleId></ArticleIdList></Reference><Reference><Citation>Guesnet P, Alessandri J-M. Docosahexaenoic acid (DHA) and the developing central nervous system (CNS) - Implications for dietary recommendations. Biochimie. 2011;93:7&#x2013;12. doi: 10.1016/j.biochi.2010.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2010.05.005</ArticleId><ArticleId IdType="pubmed">20478353</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee LK, Shahar S, Chin A-V, Yusoff NAM. Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial. Psychopharmacology. 2013;225:605&#x2013;612. doi: 10.1007/s00213-012-2848-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00213-012-2848-0</ArticleId><ArticleId IdType="pubmed">22932777</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva EV, Ayala V, Jov&#xe9; M, Dalf&#xf3; E, Cacabelos D, Povedano M, et al. Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis. Brain. 2007;130:3111&#x2013;3123. doi: 10.1093/brain/awm190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awm190</ArticleId><ArticleId IdType="pubmed">17716997</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernando S, Requejo C, Herran E, Ruiz-Ortega JA, Morera-Herreras T, Lafuente JV, et al. Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson&#x2019;s disease: The role of glia and NRf2 regulation. Neurobiol. Dis. 2019;121:252&#x2013;262. doi: 10.1016/j.nbd.2018.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.10.001</ArticleId><ArticleId IdType="pubmed">30296616</ArticleId></ArticleIdList></Reference><Reference><Citation>Srikanth M, Chandrasaharan K, Zhao X, Chayaburakul K, Ong W-Y, Herr DR. Metabolism of Docosahexaenoic Acid (DHA) Induces Pyroptosis in BV-2 Microglial Cells. Neuromolecul. Med. 2018;20:504&#x2013;514. doi: 10.1007/s12017-018-8511-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-018-8511-0</ArticleId><ArticleId IdType="pubmed">30232677</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M-M, Ding L, Wen M, Che H-X, Huang J-Q, Zhang T-T, et al. Mechanisms of DHA-enriched phospholipids in improving cognitive deficits in aged SAMP8 mice with high-fat diet. J. Nutr. Biochem. 2018;59:64&#x2013;75. doi: 10.1016/j.jnutbio.2018.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2018.05.009</ArticleId><ArticleId IdType="pubmed">29986309</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajith TA. A Recent Update on the Effects of Omega-3 Fatty Acids in Alzheimer&#x2019;s Disease. Curr Clin Pharmacol. 2018;13:252&#x2013;260. doi: 10.2174/1574884713666180807145648.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1574884713666180807145648</ArticleId><ArticleId IdType="pubmed">30084334</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva RV, Oliveira JT, Santos BLR, Dias FC, Martinez AMB, Lima CKF, et al. Long-Chain Omega-3 Fatty Acids Supplementation Accelerates Nerve Regeneration and Prevents Neuropathic Pain Behavior in Mice. Front. Pharmacol. 2017;8:723. doi: 10.3389/fphar.2017.00723.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2017.00723</ArticleId><ArticleId IdType="pmc">PMC5651013</ArticleId><ArticleId IdType="pubmed">29089890</ArticleId></ArticleIdList></Reference><Reference><Citation>Cacabelos D, Ayala V, Ram&#xed;rez-Nunez O, Granado-Serrano AB, Boada J, Serrano JCE, et al. Dietary lipid unsaturation influences survival and oxidative modifications of an amyotrophic lateral sclerosis model in a gender-specific manner. Neuromolecul. Med. 2014;16:669&#x2013;685. doi: 10.1007/s12017-014-8317-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-014-8317-7</ArticleId><ArticleId IdType="pubmed">24980941</ArticleId></ArticleIdList></Reference><Reference><Citation>Calon F, Lim GP, Yang F, Morihara T, Teter B, Ubeda O, et al. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer&#x2019;s disease mouse model. Neuron. 2004;43:633&#x2013;645. doi: 10.1016/j.neuron.2004.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.08.013</ArticleId><ArticleId IdType="pmc">PMC2442162</ArticleId><ArticleId IdType="pubmed">15339646</ArticleId></ArticleIdList></Reference><Reference><Citation>Muntan&#xe9; G, Janu&#xe9; A, Fernandez N, Odena MA, Oliveira E, Boluda S, et al. Modification of brain lipids but not phenotype in alpha-synucleinopathy transgenic mice by long-term dietary n-3 fatty acids. Neurochem. Int. 2010;56:318&#x2013;328. doi: 10.1016/j.neuint.2009.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2009.10.015</ArticleId><ArticleId IdType="pubmed">19913586</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976;72:248&#x2013;254. doi: 10.1016/0003-2697(76)90527-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-2697(76)90527-3</ArticleId><ArticleId IdType="pubmed">942051</ArticleId></ArticleIdList></Reference><Reference><Citation>Pamplona R, Dalf&#xf3; E, Ayala V, Bellmunt MJ, Prat J, Ferrer I, et al. Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation. Effects of Alzheimer disease and identification of lipoxidation targets. J. Biol. Chem. 2005;280:21522&#x2013;21530. doi: 10.1074/jbc.M502255200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M502255200</ArticleId><ArticleId IdType="pubmed">15799962</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 2006;83:1505S&#x2013;1519S.</Citation><ArticleIdList><ArticleId IdType="pubmed">16841861</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein JD, Jin L, Dykes-Hoberg M, Kuncl RW. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. Natl. Acad. Sci. USA. 1993;90:6591&#x2013;6595. doi: 10.1073/pnas.90.14.6591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.90.14.6591</ArticleId><ArticleId IdType="pmc">PMC46978</ArticleId><ArticleId IdType="pubmed">8393571</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasband WS. US National Institutes of Health, Bethesda, Maryland, USA. http://imagej.nih.gov/ij/. 2011;</Citation></Reference><Reference><Citation>Dyall SC. Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Front. Aging Neurosci. 2015;7:52. doi: 10.3389/fnagi.2015.00052.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2015.00052</ArticleId><ArticleId IdType="pmc">PMC4404917</ArticleId><ArticleId IdType="pubmed">25954194</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguirre N, Beal MF, Matson WR, Bogdanov MB. Increased oxidative damage to DNA in an animal model of amyotrophic lateral sclerosis. Free Radic. Res. 2005;39:383&#x2013;388. doi: 10.1080/10715760400027979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10715760400027979</ArticleId><ArticleId IdType="pubmed">16028363</ArticleId></ArticleIdList></Reference><Reference><Citation>Farg MA, Konopka A, Soo KY, Ito D, Atkin JD. The DNA damage response (DDR) is induced by the C9orf72 repeat expansion in amyotrophic lateral sclerosis. Hum. Mol. Genet. 2017;26:2882&#x2013;2896. doi: 10.1093/hmg/ddx170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx170</ArticleId><ArticleId IdType="pubmed">28481984</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller AF, Gravel M, Kriz J. Live imaging of amyotrophic lateral sclerosis pathogenesis: disease onset is characterized by marked induction of GFAP in Schwann cells. Glia. 2009;57:1130&#x2013;1142. doi: 10.1002/glia.20836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20836</ArticleId><ArticleId IdType="pubmed">19115383</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito D, Imai Y, Ohsawa K, Nakajima K, Fukuuchi Y, Kohsaka S. Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res. Mol. Brain Res. 1998;57:1&#x2013;9. doi: 10.1016/S0169-328X(98)00040-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0169-328X(98)00040-0</ArticleId><ArticleId IdType="pubmed">9630473</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorge RE, Mapplebeck JCS, Rosen S, Beggs S, Taves S, Alexander JK, et al. Different immune cells mediate mechanical pain hypersensitivity in male and female mice. Nat. Neurosci. 2015;18:1081&#x2013;1083. doi: 10.1038/nn.4053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4053</ArticleId><ArticleId IdType="pmc">PMC4772157</ArticleId><ArticleId IdType="pubmed">26120961</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitson AP, Stroud CK, Stark KD. Elevated production of docosahexaenoic acid in females: potential molecular mechanisms. Lipids. 2010;45:209&#x2013;224. doi: 10.1007/s11745-010-3391-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11745-010-3391-6</ArticleId><ArticleId IdType="pubmed">20151220</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterniti I, Impellizzeri D, Di Paola R, Esposito E, Gladman S, Yip P, et al. Docosahexaenoic acid attenuates the early inflammatory response following spinal cord injury in mice: in-vivo and in-vitro studies. J. Neuroinflammation. 2014;11:6. doi: 10.1186/1742-2094-11-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-11-6</ArticleId><ArticleId IdType="pmc">PMC3895696</ArticleId><ArticleId IdType="pubmed">24405628</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip PK, Pizzasegola C, Gladman S, Biggio ML, Marino M, Jayasinghe M, et al. The omega-3 fatty acid eicosapentaenoic acid accelerates disease progression in a model of amyotrophic lateral sclerosis. PLoS One. 2013;8:e61626. doi: 10.1371/journal.pone.0061626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0061626</ArticleId><ArticleId IdType="pmc">PMC3631166</ArticleId><ArticleId IdType="pubmed">23620776</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lima A, IV, Bastos LFS, Limbor&#xe7;o-Filho M, Fiebich BL, de Oliveira ACP. Role of prostaglandins in neuroinflammatory and neurodegenerative diseases. Mediators Inflamm. 2012;2012:946813. doi: 10.1155/2012/946813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/946813</ArticleId><ArticleId IdType="pmc">PMC3385693</ArticleId><ArticleId IdType="pubmed">22778499</ArticleId></ArticleIdList></Reference><Reference><Citation>Khairallah RJ, Sparagna GC, Khanna N, O&#x2019;Shea KM, Hecker PA, Kristian T, et al. Dietary supplementation with docosahexaenoic acid, but not eicosapentaenoic acid, dramatically alters cardiac mitochondrial phospholipid fatty acid composition and prevents permeability transition. Biochim. Biophys. Acta. 1797;2010:1555&#x2013;1562.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3071681</ArticleId><ArticleId IdType="pubmed">20471951</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes AE, Ferraiuolo L, Haidet-Phillips AM, Schmelzer L, Braun L, Miranda CJ, et al. Microglia induce motor neuron death via the classical NF-&#x3ba;B pathway in amyotrophic lateral sclerosis. Neuron. 2014;81:1009&#x2013;1023. doi: 10.1016/j.neuron.2014.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.013</ArticleId><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>I&#x142;zecka J. Prostaglandin E2 is increased in amyotrophic lateral sclerosis patients. Acta Neurol. Scand. 2003;108:125&#x2013;129. doi: 10.1034/j.1600-0404.2003.00102.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0404.2003.00102.x</ArticleId><ArticleId IdType="pubmed">12859290</ArticleId></ArticleIdList></Reference><Reference><Citation>Serhan CN, Krishnamoorthy S, Recchiuti A, Chiang N. Novel anti-inflammatory--pro-resolving mediators and their receptors. Curr. Top. Med. Chem. 2011;11:629&#x2013;647. doi: 10.2174/1568026611109060629.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026611109060629</ArticleId><ArticleId IdType="pmc">PMC3094721</ArticleId><ArticleId IdType="pubmed">21261595</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaudszus A, Gruen M, Watzl B, Ness C, Roth A, Lochner A, et al. Evaluation of suppressive and pro-resolving effects of EPA and DHA in human primary monocytes and T-helper cells. J. Lipid Res. 2013;54:923&#x2013;935. doi: 10.1194/jlr.P031260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.P031260</ArticleId><ArticleId IdType="pmc">PMC3605999</ArticleId><ArticleId IdType="pubmed">23349208</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald KC, O&#x2019;Reilly &#xc9;J, Falcone GJ, McCullough ML, Park Y, Kolonel LN, et al. Dietary &#x3c9;-3 polyunsaturated fatty acid intake and risk for amyotrophic lateral sclerosis. JAMA Neurol. 2014;71:1102&#x2013;1110. doi: 10.1001/jamaneurol.2014.1214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.1214</ArticleId><ArticleId IdType="pmc">PMC4160351</ArticleId><ArticleId IdType="pubmed">25023276</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>